ConductScience.org, home

Paper8782822

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.

Sakamuro D and 3 others. Nat Genet, 1996. Cited by 325 papers, by iCite.

Cite this record

ConductScience Library. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Papers, record 8782822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8782822

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
PubMed
Journal
Nat Genet
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
325
iCite
Relative citation ratio, by iCite
5.67
iCite
Revised in PubMed
2022-04-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakamuro DD
2Elliott KJK J
3Wechsler-Reya RR
4Prendergast GCG C

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carrier ProteinsMajor topic
Genes, Tumor SuppressorMajor topic
Nuclear ProteinsMajor topic
Saccharomyces cerevisiae ProteinsMajor topic
Tumor Suppressor ProteinsMajor topic
Adaptor Proteins, Signal Transducing
Amino Acid Sequence
Animals
Base Sequence
Cell Division
Cell Line
Cell Transformation, Neoplastic
DNA Primers
Fungal Proteins
Genes, myc
HeLa Cells
Humans
Microfilament Proteins
Molecular Sequence Data
Nerve Tissue Proteins
Transformation, Genetic
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA09171NCI NIH HHSUnited StatesPubMedPubMed
CA10815NCI NIH HHSUnited StatesP01CA010815PubMed and NIHNIH RePORTER
CA66179NCI NIH HHSUnited StatesPubMedPubMed
P30CA010815NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8782810MYC family ties.https://conductscience.org/library/papers/8782810

Source PubMed

Download CSV of comments and corrections

Cited by146

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 325 citations.

PMIDTitleJournalYearIn PapersSource
42650103RNA Splicing Dysregulation in Parkinson's Disease.Genes (Basel)2026https://conductscience.org/library/papers/42650103PubMed
41413653Phase separation drives cortical enrichment of the F-BAR proteins Rga7 and Rga8 to maintain cell integrity.Cell Mol Life Sci2025https://conductscience.org/library/papers/41413653PubMed
41250205tRNA-derived fragment tRF-24 drives CELF1 phase separation to promote oncogenic splicing in esophageal squamous cell carcinoma.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41250205PubMed
40808414Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer's disease.Neural Regen Res2026https://conductscience.org/library/papers/40808414PubMed
40406608Conformational modulation of intrinsically disordered transactivation domains for cancer therapy.PNAS Nexus2025https://conductscience.org/library/papers/40406608PubMed
40392240Bend it like BIN1: how a membrane-curving adaptor protein shapes cardiac physiology.Am J Physiol Heart Circ Physiol2025https://conductscience.org/library/papers/40392240PubMed
40370532Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease.Acta Pharm Sin B2025https://conductscience.org/library/papers/40370532PubMed
40308061BIN1 gene replacement reverses BIN1-related centronuclear myopathy.Mol Ther2025https://conductscience.org/library/papers/40308061PubMed
40042903BIN1 reduction ameliorates DNM2-related Charcot-Marie-Tooth neuropathy.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40042903PubMed
40016843BIN1 inhibited tumor growth, metastasis and stemness by ALDH1/NOTCH pathway in bladder carcinoma.Hereditas2025https://conductscience.org/library/papers/40016843PubMed
39859561Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD).Int J Mol Sci2025https://conductscience.org/library/papers/39859561PubMed
39452773Molecular Dynamics Reveal Key Steps in BAR-Related Membrane Remodeling.Pathogens2024https://conductscience.org/library/papers/39452773PubMed
39171951BIN1 deficiency enhances ULK3-dependent autophagic flux and reduces dendritic size in mouse hippocampal neurons.Autophagy2025https://conductscience.org/library/papers/39171951PubMed
37859648An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes.Front Neurol2023https://conductscience.org/library/papers/37859648PubMed
37847429BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.Neurotox Res2023https://conductscience.org/library/papers/37847429PubMed
37247278High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.Asian Pac J Cancer Prev2023https://conductscience.org/library/papers/37247278PubMed
37217614Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.Mol Biol Rep2023https://conductscience.org/library/papers/37217614PubMed
36890396BIN1 in cancer: biomarker and therapeutic target.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/36890396PubMed
36453088A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latency.J Med Virol2023https://conductscience.org/library/papers/36453088PubMed
35983068NF-κB in neurodegenerative diseases: Recent evidence from human genetics.Front Mol Neurosci2022https://conductscience.org/library/papers/35983068PubMed

See all 146 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BIN1274Swiss-Prot's referenceshttps://conductscience.org/library/genes/274NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKU68485

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8782822

GET https://conductscience.org/api/papers/v1/8782822/cited_by?page=2